RankingsPricing
  1. JP-listed companies
  2. Oncolys BioPharma Inc.
  3. Financials
  4. Long-term debt, non-current

Oncolys BioPharma Inc.【JP:4588】

Market cap
¥37.9B
P/E ratio
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndLong-term debt, non-current (Million JPY)YoY (%)
Dec 31, 2024167+3.45%
Dec 31, 2023161+3.57%
Dec 31, 2022156-39.13%
Dec 31, 2021256-30.30%
Dec 31, 2020367-5.72%
Dec 31, 2019389+25.00%
Dec 31, 2018311-9.68%
Dec 31, 2017344+14.81%
Dec 31, 2016300-1.06%
Dec 31, 2015303-9.90%
Dec 31, 2014337

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)